PRMT5 and cancer: These data are in line with observations made by Brehmer et al., whose explanation for MTAP-expressing, sensitive cancer cells is the mode of inhibition of PRMT5 by JNJ-64619178, which binds to the S-adenosylmethionine- and the substrate-pocket (33).